Provided by Tiger Fintech (Singapore) Pte. Ltd.

ABVC BioPharma, Inc.

0.8760
+0.04455.35%
Post-market: 0.88000.0040+0.46%19:55 EDT
Volume:124.89K
Turnover:105.57K
Market Cap:13.18M
PE:-2.09
High:0.8760
Open:0.8200
Low:0.8060
Close:0.8315
Loading ...
Jul 28, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jul 21, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jun 21, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jun 08, 2021

Major Issues Report

8-K/A [Amend] - Current report
May 14, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
May 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 03, 2021

Major Issues Report

8-K/A [Amend] - Current report
Apr 08, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Mar 16, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 11, 2021

Major Issues Report

8-K - Current report
Jan 08, 2021

Major Issues Report

8-K - Current report
Jan 07, 2021

Major Issues Report

8-K - Current report
Dec 22, 2020

Correspondence

CORRESP [Cover] - Correspondence
Dec 15, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Dec 15, 2020

Correspondence

CORRESP [Cover] - Correspondence
Nov 24, 2020

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Nov 17, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 17, 2020

Major Issues Report

8-K - Current report
Nov 05, 2020

Major Issues Report

8-K - Current report
Oct 06, 2020

Major Issues Report

8-K - Current report